Gilder Gagnon Howe & Co’s Biohaven BHVN Stock Holding History

Gilder Gagnon Howe & Co’s Portfolio BHVN Stock Details BHVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-20,673	Closed	-$1.13M	–	254
2024 Q1	$1.13M	Sell	20,673 -9,179	-31%	-$454K	0.01%	208
2023 Q4	$1.28M	Buy	29,852 +4,322	+17%	+$134K	0.02%	196
2023 Q3	$664K	Sell	25,530 -65	-0.3%	-$1.35K	0.01%	222
2023 Q2	$612K	Buy	+25,595	New	+$441K	0.01%	241

Other funds holding BHVN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

RP Management New York $139M AUM 37.98% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Gilder Gagnon Howe & Co's BHVN Position: Q2 2024 in Review

Gilder Gagnon Howe & Co sold out of Biohaven (BHVN) in Q2 2024, closing a stake of 20,673 shares — an estimated $1.13M sold.

Gilder Gagnon Howe & Co first reported a position in BHVN in Q2 2023 and held it in 4 quarters. The position peaked at $1.28M in Q4 2023. 225 funds tracked by Wall St. Rank hold BHVN as of Q2 2024.

Gilder Gagnon Howe & Co reported no remaining Biohaven position as of Q2 2024 after selling out during the quarter.
Gilder Gagnon Howe & Co sold 20,673 Biohaven shares in Q2 2024, an estimated $1.13M.
Gilder Gagnon Howe & Co first reported a position in Biohaven in Q2 2023 and held it in 4 quarters.
Gilder Gagnon Howe & Co's Biohaven position peaked at $1.28M in Q4 2023.
225 funds tracked by Wall St. Rank held Biohaven as of Q2 2024.

Based on Gilder Gagnon Howe & Co's 13F filing for Q2 2024, filed 14 Aug 2024.